普莱柯(603566) - 2017 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders decreased by 40.83% to CNY 92,422,482.76 year-to-date[8] - Operating revenue for the first nine months decreased by 10.70% to CNY 381,115,087.70 compared to the same period last year[8] - Basic earnings per share decreased by 40.82% to CNY 0.29[8] - Net profit decreased by 40.83% to ¥92,422,482.76 from ¥156,207,852.65, attributed to reduced government procurement income and lower technology licensing revenue[17] - Year-to-date net profit for the first nine months of 2017 was ¥84,787,025.41, down 42.6% from ¥147,756,797.68 in the same period last year[29] - The total profit for the first nine months of 2017 was ¥98,252,355.71, a decrease of 44.9% from ¥178,183,959.64 in the same period of 2016[35] Revenue Breakdown - Revenue from government procurement of pig vaccines dropped by 70.77% to CNY 26,518,504.53 year-to-date[14] - Revenue from market sales of pig vaccines increased by 17.19% to CNY 91,935,455.71 year-to-date[14] - Revenue from chemical drugs increased by 12.30% to CNY 113,678,947.75 year-to-date[14] Cash Flow - Cash flow from operating activities decreased by 34.27% to CNY 67,291,793.28 year-to-date[8] - Operating cash flow decreased by 34.27% to ¥67,291,793.28 from ¥102,379,283.43, mainly due to decreased accounts receivable collections[18] - Cash inflow from operating activities for the year-to-date period was CNY 389,672,430.76, a decrease of 4.4% compared to CNY 406,258,015.99 in the same period last year[37] - Net cash flow from operating activities decreased to CNY 67,291,793.28, down 34.3% from CNY 102,379,283.43 year-on-year[37] - Total cash inflow from operating activities was CNY 296,729,253.24, a decrease of 8.4% from CNY 323,765,702.52 in the same quarter last year[41] - The net cash flow from operating activities for the third quarter was CNY 54,186,567.61, down 35.0% from CNY 83,417,246.46 year-on-year[41] Assets and Liabilities - Total assets increased by 1.86% to CNY 1,769,144,640.63 compared to the end of the previous year[8] - Total assets as of September 30, 2017, were ¥1,714,697,670.33, an increase from ¥1,684,027,570.35 at the beginning of the year[27] - Total liabilities as of September 30, 2017, were ¥203,293,204.76, down from ¥212,909,606.23 at the beginning of the year[27] - Total equity attributable to shareholders was ¥1,511,404,465.57, an increase from ¥1,471,117,964.12 at the beginning of the year[27] Cash and Cash Equivalents - Cash and cash equivalents decreased by 54.79% to ¥193,776,049.33 from ¥428,628,319.95 due to the purchase of financial products[15] - Cash and cash equivalents decreased to ¥142,012,206.56 from ¥359,042,606.01 at the beginning of the year, representing a decline of 60.5%[25] - The ending balance of cash and cash equivalents was CNY 183,645,924.69, down from CNY 249,415,770.50 year-on-year[38] Investment Activities - Investment cash inflow increased by 72.29% to ¥1,318,000,000.00 from ¥765,000,000.00, primarily from the maturity of financial products[18] - Cash inflow from investment activities totaled CNY 1,331,581,811.21, significantly higher than CNY 776,396,858.43 in the previous year, marking an increase of 71.2%[38] - Cash outflow for investment activities reached CNY 1,565,644,043.93, up 64.3% from CNY 953,218,948.69 in the same period last year[38] Operating Costs - Total operating costs for Q3 2017 were ¥109,744,717.59, slightly up from ¥109,182,196.65 in Q3 2016[29] - Year-to-date total operating costs for the first nine months of 2017 were ¥307,233,949.21, an increase of 6.2% compared to ¥289,272,993.31 in the same period last year[29] - The company's operating costs for Q3 2017 were ¥24,563,831.70, down 26.0% from ¥33,133,443.16 in Q3 2016[33] Non-Recurring Items - Non-recurring gains and losses totaled CNY 18,707,229.88 for the reporting period[11] - The company reported a significant decrease in non-operating income by 39.15% to ¥20,959,315.53 from ¥34,444,535.03, due to reduced government subsidies[17] - The company reported a tax expense of ¥2,967,352.32 for Q3 2017, a decrease of 65.5% from ¥8,607,366.75 in Q3 2016[35]